Guanylin peptide family: History, interactions with ANP, and new pharmacological perspectives

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 8, 2011, Pages 575-585

  Fonteles, Manassés Claudino ^a   do Nascimento, Nilberto Robson Falcão ^a  

^a STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Atriopeptins; Guanylins; Natriuretic peptides erectile dysfunction; Particulate guanylate cyclase; Penile erection; Salt metabolism

Indexed keywords

7 NITROINDAZOLE; ATRIAL NATRIURETIC FACTOR; CELL SURFACE RECEPTOR; CYCLIC GMP; ENKEPHALINASE INHIBITOR; ESCHERICHIA COLI ENTEROTOXIN; GUANYLATE CYCLASE; GUANYLIN; ISATIN; UROGUANYLIN; VARDENAFIL;

ARTICLE; DIABETES MELLITUS; DIGESTIVE SYSTEM; DISULFIDE BOND; DIURESIS; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; EX VIVO STUDY; HUMAN; IN VIVO STUDY; INTESTINE; KALIURESIS; KIDNEY CELL; NATRIURESIS; NONHUMAN; PENIS ERECTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM URINE LEVEL; TARGET CELL; THERMOSTABILITY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; GASTROINTESTINAL HORMONES; GUANYLATE CYCLASE; HUMANS; NATRIURETIC PEPTIDES;

EID: 79961199719     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-050     Document Type: Article

References (90)

1. Aizawa, N., Ishizuka, O., Ogawa, T., Mizusawa, H., Igawa, Y., Nishizawa, O., and Andersson, K.E. 2008. Effects of natriuretic peptides on intracavernous pressure and blood pressure in conscious rats. J. Sex. Med. 5(10): 2312-2317. PMID:18624958.
2. Amorim, J.B., Musa-Aziz, R., Lessa, L.M., Malnic, G., and Fonteles, M.C. 2006. Effect of uroguanylin on potassium and bicarbonate transport in rat renal tubules. Can. J. Physiol. Pharmacol. 84(10): 1003-1010. doi:10.1139/y06-044. PMID:17218966.
3. Anand-Srivastava, M.B. 2005. Natriuretic peptide receptor-C signaling and regulation. Peptides, 26(6): 1044-1059. doi:10.1016/j. peptides.2004.09.023. PMID:15911072.
4. Anand-Srivastava, M.B., Sehl, P.D., and Lowe, D.G. 1996. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J. Biol. Chem. 271(32): 19324-19329. doi:10.1074/jbc. 271.32.19324. PMID:8702617.
5. Andersson, K.E., and Wagner, G. 1995. Physiology of penile erection. Physiol. Rev. 75(1): 191-236. PMID:7831397.
6. Boolell, M., Allen, M.J., Ballard, S.A., Gepi-Attee, S., Muirhead, G. J., Naylor, A.M., et al. 1996. Sildenafil: An orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8(2): 47-52. PMID:8858389.
7. Burnett, A.L., Lowenstein, C.J., Bredt, D.S., Chang, T.S., and Snyder, S.H. 1992. Nitric oxide: a physiologic mediator of penile erection. Science, 257(5068): 401-403. doi:10.1126/science. 1378650. PMID:1378650.
8. Carey, R.M. 1978. Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man: lack of dependence upon aldosterone. Circ. Res. 43(1): 19-23. PMID:657455.
9. Carey, R.M., Smith, J.R., and Ortt, E.M. 1976. Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits. Am. J. Physiol. 230(6): 1504-1508. PMID:937539.
10. Carrithers, S.L., Hill, M.J., Johnson, B.J., O'Hara, S.M., Jackson, B. A., Ott, C.E., et al. 1999. Renal effects of uroguanylin and guanylin in vivo. Braz. J. Med. Biol. Res. 32(11): 1337-1344. doi:10.1590/S0100-879X1999001100003. PMID:10559834.
11. Carrithers, S.L., Eber, S.L., Forte, L.R., and Greenberg, R.N. 2000a. Increased urinary excretion of uroguanylin in patients with congestive heart failure. Am. J. Physiol. Heart Circ. Physiol. 278(2): H538- H547. PMID:10666086.
12. Carrithers, S.L., Taylor, B., Cai, W.Y., Johnson, B.R., Ott, B.R., Greenberg, R.N., and Jackson, B.A. 2000b. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron. Regul. Pept. 95 (1-3): 65-74. doi:10.1016/S0167-0115(00)00139-7. PMID: 11062334.
13. Carrithers, S.L., Jackson, B.A., Cai, W.Y., Greenberg, R.N., and Ott, C.E. 2002. Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine. Regul. Pept. 107(1-3): 87-95. doi:10.1016/S0167-0115(02)00069-1. PMID: 12137970.
14. Carrithers, S.L., Ott, C.E., Hill, M.J., Johnson, B.R., Cai, W., Chang, J.J., et al. 2004. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C. Kidney Int. 65(1): 40-53. doi:10. 1111/j.1523-1755.2004.00375.x. PMID:14675035.
15. Cohen, M.B., Witte, D.P., Hawkins, J.A., and Currie, M.G. 1995. Immunohistochemical localization of guanylin in the rat small intestine and colon. Biochem. Biophys. Res. Commun. 209(3): 803-808. doi:10.1006/bbrc.1995.1571. PMID:7733972.
16. Currie, M.G., Fok, K.F., Kato, J., Moore, R.J., Hamra, F.K., Duffin, K.L., and Smith, C.E. 1992. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 89(3): 947-951. doi:10.1073/pnas.89.3.947. PMID:1346555.
17. Dai, Y., Chitaley, K., Webb, R.C., Lewis, R.W., and Mills, T.M. 2004. Topical application of a Rho-kinase inhibitor in rats causes penile erection. Int. J. Impot. Res. 16(3): 294-298. doi:10.1038/sj. ijir.3901171. PMID:14961052.
18. Davies, K.P., Tar, M., Rougeot, C., and Melman, A. 2007. Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat. BJU Int. 99(2): 431-435. doi:10.1111/j.1464-410X.2006.06577.x. PMID:17026587.
19. de Bold, A.J., and Flynn, T.G. 1983. Cardionatrin I - a novel heart peptide with potent diuretic and natriuretic properties. Life Sci. 33(3): 297-302. doi:10.1016/0024-3205(83)90390-9. PMID:6223192.
20. de Bold, A.J., Borenstein, H.B., Veress, A.T., and Sonnenberg, H. 1981. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28(1): 89-94. doi:10.1016/0024-3205(81)90370-2. PMID:7219045.
21. Elitsur, N., Lorenz, J.N., Hawkins, J.A., Rudolph, J.A., Witte, D., Yang, L.E., et al. 2006. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response. J. Pediatr. Gastroenterol. Nutr. 43(Suppl. 1): S74-S81. doi:10.1097/01.mpg. 0000228092.36089.7c. PMID:16819406.
22. Fan, X., Hamra, F.K., Freeman, R.H., Eber, S.L., Krause, W.J., Lim, R.W., et al. 1996. Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma. Biochem. Biophys. Res. Commun. 219(2): 457-462. doi:10.1006/bbrc. 1996.0255. PMID:8605009.
23. Fan, X., Hamra, F.K., London, R.M., Eber, S.L., Krause, W.J., Freeman, W.H., et al. 1997. Structure and activity of uroguanylin and guanylin from urine and intestine of rats. Am. J. Physiol. Renal Physiol. 273(5 Pt. 1): E957-E964. PMID:9374682.
24. Fonteles, M.C., and Lima, A.A.M. 1983. Efeitos das toxinas do V. Cholerae e da E. coli no rim perfundido. In Proceedings of the XVIII Congresso Brasileiro de Fisiologia, 17-20 April 1983, São Lourenço, Minas Gerais, Brazil. FeSBE, São Paulo, Brazil. S-31: 46.
25. Fonteles, M.C., Viossat, I., Helleguarch, A., Chabrier, P., and Pirotzky, E. 1990. The presence of ANF like material in the perfused rabbit kidney. Eur. J. Pharmacol. 183(3): 1052-1053. doi:10.1016/0014-2999(90)92911-2.
26. Fonteles, M.C., Lima, A.A.M., Fang, G., and Guerrant, R.L. 1991. Effect of STa and cholera toxin on renal eletrolyte transport: possible roles of an endogenous ST-like compound in the isolated kidney. In Proceedings of the 27th US Japan Cholera Meeting, Charlottesville, Va., 25-27 September 1991. UVA Press, Va. pp. 100-105.
27. Fonteles, M.C., Villar-Palasi, C., Fang, G., Larner, J., and Guerrant, R.L. 1993. Partial characterization of an ANF/urodilatin-like substance released from perfused rabbit kidney under hypoxia. Braz. J. Med. Biol. Res. 26(1): 75-79. PMID:8220271.
28. Fonteles, M.C., Monteiro, H.S.A., Soares, A.M., Santos-Neto, M.S., Greenberg, R.N., and Lima, A.A.M. 1996. The lysine-1 analog of guanylin induces intestinal secretion and natriuresis in the isolated perfused kidney. Braz. J. Med. Biol. Res. 29(2): 267-271. PMID: 8731359.
29. Fonteles, M.C., Greenberg, R.N., Monteiro, H.S.A., Currie, M.G., and Forte, L.R. 1998. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am. J. Physiol. 275(2 Pt 2): F191-F197. PMID:9691007.
30. Fonteles, M.C., Carrithers, S.L., Monteiro, H.S.A., Carvalho, A.F., Coelho, G.R., Greenberg, R.N., and Forte, L.R. 2001. Renal effects of serine-7 analog of lymphoguanylin in ex vivo rat kidney. Am. J. Physiol. 280(2): F207-F213. PMID:11208595.
31. Fonteles, M.C., Sousa, C.M., Cerqueira, J.B.G., Batista, F.J.A., Santos, C.F., Silva, L.F.G., and Nascimento, N.R.F. 2007. Uroguanylin relaxes human corpus cavernosum and is potentiated by vardenafil. FASEB J. 21: 571.
32. Fonteles, M.C., Havt, A., Prata, R.B., Prata, P.H., Monteiro, H.S., Lima, A.A., et al. 2009. High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion. Regul. Pept. 158(1-3): 6-13. doi:10.1016/j.regpep. 2009.07.011. PMID:19632278.
33. Forte, L.R. 2003. A novel role for uroguanylin in the regulation of sodium balance. J. Clin. Invest. 112(8): 1138-1141. PMID: 14561698.
34. Forte, L.R., Jr. 2004. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol. Ther. 104(2): 137-162. doi:10.1016/j.pharmthera.2004.08.007. PMID: 15518884.
35. Forte, L.R., Jr. 2005. Uroguanylin: physiological role as a natriuretic hormone. J. Am. Soc. Nephrol. 16(2): 291-292. doi:10.1681/ASN. 2004121061. PMID:15647333.
36. Forte, L.R., and Fonteles, M.C. 2008. Uroguanylin and guanylin: endocrine link connecting the intestine and kidney for regulation of sodium balance. Seldin and Giebisch's The Kidney: Physiology and Pathophysiologylogy. 4th ed. Edited by R.J. Alpern and S.C. Hebert. Academic Press, London, UK. pp. 463-478.
37. Forte, L.R., Krause, W.J., and Freeman, R.H. 1988. Receptors and cGMP signaling mechanism for E. coli enterotoxin in opossum kidney. Am. J. Physiol. 255(5 Pt 2): F1040-F1046. PMID: 2847547.
38. Forte, L.R., Krause, W.J., and Freeman, R.H. 1989. Escherichia coli enterotoxin receptors: localization in opossum kidney, intestine and testis. Am. J. Physiol. 257(5 Pt 2): F874-F881. PMID: 2556042.
39. Forte, L.R., Eber, S.L., Fan, X., London, R.M., Wang, Y., Rowland, L.M., et al. 1999. Lymphoguanylin: Cloning and characterization of a unique member of the guanylin peptide family. Endocrinology, 140(4): 1800-1806. doi:10.1210/en.140.4.1800. PMID: 10098518.
40. Fujimoto, S., Kinoshita, K., Hara, S., Nakazato, M., Hisanaga, S., and Eto, T. 2000. Immuno histochemical localization of uroguanylin in the human kidney. Nephron, 84(1): 88-89. doi:10.1159/ 000045548. PMID:10644918.
41. Fukae, H., Kinoshita, H., Fujimoto, S., Kita, T., Nakazato, M., and Eto, T. 2002. Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats. Nephron, 92(2): 373-378. doi:10.1159/000063311. PMID:12218317.
42. Gariépy J., Judd A.K., and Schoolnik G.K. 1987. Importance of disulfi de bridges in the structure and activity of Escherichia coli enterotoxin ST1b. Proc. Natl. Acad. Sci. U.S.A. 84(24): 8907-8911. doi:10.1073/pnas.84.24.8907. PMID:2827159.
43. Greenberg, R.N., Hill, M., Crytzer, J., Krause, W.J., Eber, S.L., Hamra, F.K., and Forte, L.R. 1997. Comparison of effects of uroguanylin, guanylin, Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J. Investig. Med. 45(5): 276-282. PMID:9250001.
44. Guerrant, R.L., Hughes, J.M., Chang, B., Robertson, D.C., and Murad, F. 1980. Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. J. Infect. Dis. 142(2): 220-228. doi:10.1093/infdis/142.2.220. PMID:6106030.
45. Hamra, F.K., Forte, L.R., Eber, S.L., Pidhorodeckyj, N.V., Krause, W.J., Freeman, R.H., et al. 1993. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 90(22): 10464-10468. doi:10.1073/pnas.90.22.10464. PMID:7902563.
46. Hamra, F.K., Fan, X., Krause, W.J., Freeman, R.H., Chin, D.T., Smith, C.E., et al. 1996a. Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology, 137(1): 257-265. doi:10.1210/en. 137.1.257. PMID:8536621.
47. Hamra, F.K., Krause, W.J., Eber, S.L., Freeman, R.H., Smith, C.E., Currie, M.G., and Forte, L.R. 1996b. Colonic mucosa contains uroguanylin and guanylin peptides. Am. J. Physiol. 270(4 Pt 1): G708-G716. PMID:8928802.
48. Hess, R., Kuhn, M., Schulz-Knappe, P., Raida, M., Fuchs, M., Klodt, J., et al. 1995. Isolation and characterization of the circulating form of human uroguanylin. FEBS Lett. 374(1): 34-38. doi:10.1016/ 0014-5793(95)01075-P. PMID:7589507.
49. Hughes, J.M., Murad, F., Chang, B., and Guerrant, R.L. 1978. Role of cyclic GMP in the action of heat stable enterotoxin of Escherichia coli. Nature, 271(5647): 755-756. doi:10.1038/ 271755a0. PMID:203862.
50. Kangawa, K., and Matsuo, H. 1984. Purification and complete amino acid sequence of a-human atrial natriuretic polypeptide (a-hANP). Biochem. Biophys. Res. Commun. 118(1): 131-139. doi:10.1016/ 0006-291X(84)91077-5. PMID:6230082.
51. Kikuchi, M., Fujimoto, S., Fukae, H., Kinoshita, H., Kita, T., Nakazato, M., and Eto, T. 2005. Role of uroguanylin, a peptide with natriuretic activity, in rats with experimental nephritic syndrome. J. Am. Soc. Nephrol. 16(2): 392-397. doi:10.1681/ ASN.2004040324. PMID:15590761.
52. Kim, S.Z., Kim, S.H., Park, J.K., Koh, G.Y., and Cho, K.W. 1998. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J. Urol. 159(5): 1741-1746. doi:10.1097/00005392-199805000-00104. PMID:9554404.
53. Kinoshita, H., Fujimoto, S., Nakazato, M., Yokota, N., Date, Y., Yamaguchi, H., et al. 1997. Urine and plasma levels of uroguanylin and its molecular forms in renal diseases. Kidney Int. 52(4): 1028-1034. doi:10.1038/ki.1997.424. PMID:9328941.
54. Kinoshita, H., Fujimoto, S., Fukae, H., Yokota, N., Hisanaga, S., Nakazato, M., and Eto, T. 1999. Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron, 81(2): 160-164. doi:10.1159/000045272. PMID: 9933751.
55. Kita, T., Smith, C.E., Fok, K.F., Duffin, K.L., Moore, W.M., Karabatsos, P.J., et al. 1994. Characterization of human urogua-nylin: member of the guanylin peptide family. Am. J. Physiol. 266 (2 Pt 2): F342-F348. PMID:8141334.
56. Kita, T., Kitamura, K., Sakata, J., and Eto, T. 1999. Marked increase of guanylin secretion in response to salt loading in the rat small intestine. Am. J. Physiol. 277(5 Pt 1): G960-G966. PMID: 10564101.
57. Krause, W.J., Cullingford, G.L., Freeman, R.H., Eber, S.L., Richardson, K.C., Fok, K.F., et al. 1994. Distribution of heat-stable enterotoxin/guanylin receptors in the intestinal tract of man and other mammals. J. Anat. 184(Pt 2): 407-417. PMID:8014132.
58. Kun, A., Kiraly, I., Pataricza, J., Marton, Z., Krassoi, I., Varro, A., et al. 2008. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J. Sex. Med. 5(5): 1114-1125. doi:10.1111/j.1743-6109.2008.00775.x. PMID:18312283.
59. Küthe, A., Reinecke, M., Uckert, S., Becker, A., David, I., Heitland, A., et al. 2003. Expression of guanylyl cyclase B in the human corpus carvenosum penis and the possible involvement of its ligand c-type natriuretic polypeptide in the induction of penile erection. J. Urol. 169(5): 1918-1922. doi:10.1097/01.ju. 0000055602.35858.8f. PMID:12686873.
60. Lennane, R.J., Peart, W.S., Carey, R.M., and Shaw, J.A. 1975. Comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted rabbits: evidence for a gastrointestinal or portal monitor of sodium intake. Clin. Sci. Mol. Med. 49(5): 433-436. PMID:1192700.
61. Li, Z., and Perkins, A.G. 1997. TaylorBlake B, Light AR, Goy MF. Cloning and localization of rat uroguanylin. Gastroenterology, 112: A1179.
62. Li, Z., Taylor-Blake, B., Light, A.R., and Goy M.F. 1995. Guanylin, an endogenous ligand for C-type guanylate cyclase, is produced by goblet cells in the rat intestine. Gastroenterology, 109(6): 1863-1875. doi:10.1016/0016-5085(95)90753-X. PMID:7498651.
63. Li, Z., Knowles, J.W., Goyeau, D., Prabhakar, S., Short, D.B., Perkins, A.G., and Goy, M.F. 1996. Low salt intake down-regulates the guanylin signaling pathway in rat distal colon. Gastroenterology, 111(6): 1714-1721. doi:10.1016/S0016-5085 (96)70037-9. PMID:8942754.
64. Lima, A.A., Monteiro, H.S.A., and Fonteles, M.C. 1992. The effects of Escherichia coli heat-stable enterotoxin in renal sodium tubular transport. Basic Clin. Pharmacol. Toxicol. 70(3): 163-167. doi:10. 1111/j.1600-0773.1992.tb00449.x. PMID:1315964.
65. Lorenz, J.N., Nieman, M., Sabo, J., Sanford, L.P., Hawkins, J.A., Elitsur, N., et al. 2003. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J. Clin. Invest. 112(8): 1244-1254. PMID:14561709.
66. Martin, S., Adermann, K., Forssmann, W.-G., and Kuhn, M. 1999. Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa. Endocrinology, 140(11): 5022-5029. doi:10. 1210/en.140.11.5022. PMID:10537127.
67. Moro, F., Levenez, F., Nemoz-Gaillard, E., Pellissier, S., Plaisancie, P., and Cuber, J.C. 2000. Release of guanylin immunoreactivity from the isolated vascularly perfused rat colon. Endocrinology, 141(7): 2594-2599. doi:10.1210/en.141.7.2594. PMID:10875263.
68. Moss, N.G., Fellner, R.C., Qian, X., Yu, S.J., Li, Z., Nakazato, M., and Goy, M.F. 2008. Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide. Endocrinology, 149(9): 4486-4498. doi:10.1210/en.2007-1725. PMID:18499760.
69. Moss, N.G., Riguera, D.A., Fellner, R.C., Cazzolla, C., and Goy, M. F. 2010. Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat. Am. J. Physiol. Renal Physiol. 299(6): F1433-F1442. doi:10.1152/ajprenal.00281.2010. PMID: 20861080.
70. Nakazato, M., Yamaguchi, H., Kinoshita, H., Kangawa, K., Matsuo, H., Chino, N., and Matsukura, S. 1996. Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency. Biochem. Biophys. Res. Commun. 220(3): 586-593. doi:10.1006/bbrc.1996. 0447. PMID:8607808.
71. Nakazato, M., Yamaguchi, H., Date, Y., Miyazato, M., Kangawa, K., Goy, M.F., et al. 1998. Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin. Endocrinology, 139(12): 5247-5254. doi:10.1210/en.139.12.5247. PMID: 9832465.
72. Perkins, A., Goy, M.F., and Li, Z. 1997. Uroguanylin is expressed by enterochromaffin cells in the rat gastrointestinal tract. Gastro-enterology, 113(3): 1007-1014. doi:10.1016/S0016-5085(97) 70198-7. PMID:9287996.
73. Potthast, R., Ehler, E., Scheving, L.A., Sindić, A., Schlatter, E., and Kuhn, M. 2001. High salt intake increases uroguanylin expression in mouse kidney. Endocrinology, 142(7): 3087-3097. doi:10. 1210/en.142.7.3087. PMID:11416031.
74. Qian, X., Moss, N.G., Fellner, R.C., and Goy, M.F. 2008. Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology, 149(9): 4499-4509. doi:10.1210/en.2007-1724. PMID:18499761.
75. Qian, X., Moss, N.G., Fellner, R.C., Taylor-Blake, B., and Goy, M.F. 2011. The rat kidney contains high levels of prouroguanylin, (the uroguanylin precursor), but does not express GC-C (the enteric uroguanylin receptor). Am. J. Physiol. Renal Physiol. 300(2): F561-F573. doi:10.1152/ajprenal.00282.2010. PMID:21106860.
76. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R.J., and Cohen, R.A. 1989. Impaired neurogenic and endothelium mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320(16): 1025-1030. doi:10. 1056/NEJM198904203201601. PMID:2927481.
77. Sánchez, A., Villalba, N., Martínez, A.C., Garciasacristan, A., Hernandez, M., and Prieto, D. 2008. Mechanisms of the relaxant effect of vardenafil in rat penile arteries. Eur. J. Pharmacol. 586(1-3): 283-287. doi:10.1016/j.ejphar.2008.03.002. PMID:18420189.
78. Santos-Neto, M.S., Carvalho, A.F., Monteiro, H.S., Forte, L.R., and Fonteles, M.C. 2006. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney. Regul. Pept. 136(1-3): 14-22. doi:10.1016/j.regpep.2006. 04.017. PMID:16814407.
79. Schulz, S., Chinkers, M., and Garbers, D.L. 1989. The guanylate cyclase/receptor family of proteins. FASEB J. 3(9): 2026-2035. PMID:2568301.
80. Sindić, A., and Schlatter, E. 2006. Mechanisms of action of uroguanylin and guanylin and their role in salt handling. Nephrol. Dial. Transplant. 21(11): 3007-3012. doi:10.1093/ndt/gfl314. PMID:16921192.
81. Sindić, A., Basoglu, C., Cerci, A., Hirsch, J.R., Potthast, R., Kuhn, M., et al. 2002. Guanylin, uroguanylin, and heat-stable enterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein. J. Biol. Chem. 277(20): 17758-17764. doi:10.1074/jbc. M110627200. PMID:11889121.
82. Sindić, A., Velic, A., Başoglu, C., Hirsch, J.R., Edemir, B., Kuhn, M., and Schlatter, E. 2005. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C. Kidney Int. 68(3): 1008-1017. doi:10.1111/ j.1523-1755.2005.00518.x. PMID:16105031.
83. Sousa, C.M., Havt, A., Santos, C.F., Arnaud-Batista, F.J., Cunha, K. M., Cerqueira, J.B., et al. 2010. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa. J. Sex. Med. 7(11): 3610-3619. doi:10. 1111/j.1743-6109.2009.01672.x. PMID:20102442.
84. Steinbrecher, K.A., Rudolph, J.A., Luo, G., and Cohen, M.B. 2002. Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells. Am. J. Physiol. Cell Physiol. 283(6): C1729-C1737. PMID:12388101.
85. Villar, I.C., Panayiotou, C.M., Sheraz, A., Madhani, M., Scotland, R. S., Nobles, M., et al. 2007. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc. Res. 74(3): 515-525. doi:10.1016/j.cardiores. 2007.02.032. PMID:17391657.
86. Werner, M.E., Meredith, A.L., Aldrich, R.W., and Nelson, M.T. 2008. Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295(1): R181-R188. doi:10.1152/ajpregu.00173.2008. PMID:18480246.
87. White, A.A., Krause, W.J., Turner, J.T., and Forte, L.R. 1989. Opossum kidney contains a functional receptor for the Escherichia coli heat-stable enterotoxin. Biochem. Biophys. Res. Commun. 159(1): 363-367. doi:10.1016/0006-291X(89)92447-9. PMID: 2564275.
88. Wiegand, R.C., Kato, J., and Currie, M.G. 1992a. Rat guanylin cDNA: Characterization of the precursor of the endogenous activator of intestinal guanylate cyclase. Biochem. Biophys. Res. Commun. 185(3): 812-817. doi:10.1016/0006-291X(92)91699-Q. PMID:1378267.
89. Wiegand, R.C., Kato, J., Huang, M.D., Fok, K.F., Kachur, J.F., and Currie, M.G. 1992b. Human guanylin: cDNA isolation, structure and activity. FEBS Lett. 311(2): 150-154. doi:10.1016/0014-5793 (92)81387-2. PMID:1327879.
90. Yandle, T.G. 1994. Biochemistry of natriuretic peptides. J. Intern. Med. 235(6): 561-576. doi:10.1111/j.1365-2796.1994.tb01263.x. PMID:8207362.